Jane Holmes

Adaptive designs in clinical trials: why use them, and how to run and report them

Philip Pallmann, Alun Bedding, Babak Choodari‐Oskooei et al. · BMC Medicine · 2018 · 834 citations · Full text

Public Health, Biostatistics, Evidence-based Practice +10

Molnupiravir plus usual care versus usual care alone as early treatment for adults with COVID-19 at increased risk of adverse outcomes (PANORAMIC): an open-label, platform-adaptive randomised controlled trial

Christopher Butler, Richard Hobbs, Oghenekome Gbinigie et al. · The Lancet · 2022 · 406 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +7

A family-based and case-control association study of the dopamine D4 receptor gene and dopamine transporter gene in attention deficit hyperactivity disorder

Jane Holmes, Antony Payton, Jennifer H. Barrett et al. · Molecular Psychiatry · 2000 · 147 citations

Life Sciences, Genetics, Molecular Genetics +17

Examining for association between candidate gene polymorphisms in the dopamine pathway and attention‐deficit hyperactivity disorder: A family‐based study

Antony Payton, Jane Holmes, Jennifer H. Barrett et al. · American Journal of Medical Genetics · 2001 · 126 citations

Life Sciences, Genetics, Psychiatry +15

Oseltamivir plus usual care versus usual care for influenza-like illness in primary care: an open-label, pragmatic, randomised controlled trial

Christopher Butler, Alike W. van der Velden, Emily Bongard et al. · The Lancet · 2019 · 103 citations · Full text

Medicine, Infectious Diseases, Internal Medicine +5